Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
[HTML][HTML] Ruthenium complexes as promising candidates against lung cancer
Q Sun, Y Li, H Shi, Y Wang, J Zhang, Q Zhang - Molecules, 2021 - mdpi.com
Lung cancer is one of the most common malignancies with the highest mortality rate and the
second-highest incidence rate after breast cancer, posing a serious threat to human health …
second-highest incidence rate after breast cancer, posing a serious threat to human health …
Recent advances of gold compounds in anticancer immunity
S Yue, M Luo, H Liu, S Wei - Frontiers in Chemistry, 2020 - frontiersin.org
In recent years, gold compounds have gained more and more attentions in the design of
new metal anticancer drugs. Numerous researches have reported that gold compounds, in …
new metal anticancer drugs. Numerous researches have reported that gold compounds, in …
Construction of monophosphine–metal complexes in privileged diphosphine-based covalent organic frameworks for catalytic asymmetric hydrogenation
Z Zheng, C Yuan, M Sun, J Dong, Y Liu… - Journal of the American …, 2023 - ACS Publications
Privileged diphosphine ligands that chelate many transition metals to form stable chelation
complexes are essential in a variety of catalytic processes. However, the exact identity of the …
complexes are essential in a variety of catalytic processes. However, the exact identity of the …
[HTML][HTML] Research progress on the biological activities of metal complexes bearing polycyclic aromatic hydrazones
R Liu, J Cui, T Ding, Y Liu, H Liang - Molecules, 2022 - mdpi.com
Due to the abundant and promising biological activities of aromatic hydrazones, it is of great
significance to study the biological activities of their metal complexes for the research and …
significance to study the biological activities of their metal complexes for the research and …
Metal complexes as promising matrix metalloproteinases regulators
Nowadays, cancers and dementia, such as Alzheimer's disease, are the most fatal causes of
death. Many studies tried to understand the pathogenesis of those diseases clearly and …
death. Many studies tried to understand the pathogenesis of those diseases clearly and …
Recent advancements in organotin (IV) complexes as potential anticancer agents
J Devi, J Yadav - Anti-Cancer Agents in Medicinal Chemistry …, 2018 - ingentaconnect.com
Cancer is a multistep disease incorporating physical, chemical, environmental, metabolic
and genetic factors, which play direct or indirect role in the induction and deterioration of …
and genetic factors, which play direct or indirect role in the induction and deterioration of …
Recent developments in the nanostructured materials functionalized with ruthenium complexes for targeted drug delivery to tumors
In recent years, the field of metal-based drugs has been dominated by other existing
precious metal drugs, and many researchers have focused their attention on the synthesis of …
precious metal drugs, and many researchers have focused their attention on the synthesis of …
New binuclear Ni (II) metallates containing ONS chelators: synthesis, characterisation, DNA binding, DNA cleavage, protein binding, antioxidant activity, antimicrobial …
Four new complexes with bridged bis (diphenylphosphino) ethane containing 3-methoxy
salicylaldehyde 4 (N)-substituted thiosemicarbazone were prepared and characterised by …
salicylaldehyde 4 (N)-substituted thiosemicarbazone were prepared and characterised by …
Organoruthenium metallocycle induced mutation in gld-1 tumor suppression gene in JK1466 strain and appreciable lifespan expansion
S Nandhini, M Ranjani, G Thiruppathi… - Journal of Inorganic …, 2024 - Elsevier
Abstract Four Ru (II) complexes (A2-A5) were synthesized from the reaction of coumarin
Schiff base ligands (7da2-tsc, 7da3-mtsc, 7da4-etsc and 7da5-ptsc) with [RuHCl (CO)(PPh …
Schiff base ligands (7da2-tsc, 7da3-mtsc, 7da4-etsc and 7da5-ptsc) with [RuHCl (CO)(PPh …
Synthesis of Ru (II) cyclometallated complexes via C (aryl)–S bond activation: X-ray structure, DNA/BSA protein binding and antiproliferative activity
A Das, S Mandal, R Mukherjee, R Naskar… - New Journal of …, 2023 - pubs.rsc.org
As a contribution to the development of new ruthenium complexes with pharmacologically
interesting properties, two new cyclometallated ruthenium (II) carbonyl complexes of the …
interesting properties, two new cyclometallated ruthenium (II) carbonyl complexes of the …